COMPOUNDING FINDER
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. Michigan patients with a documented clinical need may be eligible for compounded tirzepatide.
Michigan’s healthcare is anchored by Detroit, Ann Arbor, and Grand Rapids, but the Upper Peninsula and northern Lower Peninsula have fewer local pharmacy options. Compounding Finder helps Michigan residents compare licensed pharmacies statewide.
Yes. The Michigan Board of Pharmacy oversees compounding. A valid prescription with clinical justification is required.
Typically $150 to $450 per month.